20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sara Watutantrige Fernando is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario

Galuppini, F., Vianello, F., Censi, S., Barollo, S., Bertazza, L., Carducci, S., Colato, C., Manso, J., Rugge, M., Iacobone, M., Watutantrige Fernando, S., Pennelli, G. & Mian, C., Aug 7 2019, In : Frontiers in Endocrinology. 10, p. 1-11 11 p., 552.

Research output: Contribution to journalArticle

  • Prognostic significance of TERT promoter and BRAF mutations in TIR-4 and TIR-5 thyroid cytology

    Censi, S., Barollo, S., Grespan, E., Watutantrige-Fernando, S., Manso, J., Iacobone, M., Casal Ide, E., Galuppini, F., Fassina, A., Bertazza, L., Vianello, F., Pennelli, G. & Mian, C., Jul 1 2019, In : European Journal of Endocrinology. 181, 1, p. 1-11 11 p.

    Research output: Contribution to journalArticle

  • Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma

    Galuppini, F., Fassan, M., Bertazza, L., Barollo, S., Cascione, L., Watutantrige-Fernando, S., Lazzarin, V., Simonato, P., Vianello, F., Rugge, M., Mian, C. & Pennelli, G., 2019, In : Cancer Management and Research. 11, p. 7845-7855 11 p.

    Research output: Contribution to journalArticle

  • Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity?

    Censi, S., Cavedon, E., Watutantrige-Fernando, S., Barollo, S., Bertazza, L., Manso, J., Iacobone, M., Nacamulli, D., Galuppini, F., Pennelli, G. & Mian, C., Apr 2019, In : European Thyroid Journal. 8, 2, p. 108-112 5 p.

    Research output: Contribution to journalArticle

  • EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer

    Bertazza, L., Sensi, F., Cavedon, E., Watutantrige-Fernando, S., Censi, S., Manso, J., Vianello, F., Casal Ide, E., Iacobone, M., Pezzani, R., Mian, C. & Barollo, S., Jun 1 2018, In : Endocrinology. 159, 6, p. 2348-2360 13 p.

    Research output: Contribution to journalArticle